University of Montreal Hospital Center, Montreal, Quebec, Canada
Correspondence: Dang K. Nguyen
University of Montreal Health Center,
Montreal, H2X 0C1, Canada
Porphyrias are rare genetic disorders which cause a deficiency in the enzymes involved in the biosynthesis of heme. The treatment of epilepsy in patients with acute intermittent porphyria can be difficult since many anticonvulsants can increase heme synthesis and trigger porphyric attacks. We report a patient with focal epilepsy successfully treated with eslicarbazepine without exacerbation of porphyria.